Sinopharm Capital, under Sinopharm Group
, is a professional PE company specialized in medical and healthcare industry. The funds are managed by a team of Sinopharm Group senior management team members, investment bank experts and professional investors, who has profound understanding about development and operation of Chinese medical and healthcare industry and rich knowledge of capital operation.
Fortune Capital is one of the earliest market-oriented venture capital firms in China.Basing on its professionalism and good performance, Fortune Capital is now ranked among the highest performing VC/PE firms in China and selected as “Vice President of Venture Capital Committee of IAC”, “Vice President of Shenzhen VC Association”, “Vice President of Shenzhen Chamber of International Investment & Funding”,etc.
Shanghai STVC Group,directly supervised by Shanghai SASAC ,is one of the largest state-owned venture capital institutions in Shanghai and even in China. The funds under direct management amounted to 12 billion yuan .We shoulder the mission of advancing the construction of the Shanghai Science and Technology Innovation Center with global influence.